Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Huailu Tu

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Biomolecules|November 3, 2020
XIAP's Profile in Human CancerHuailu Tu, Max Costa
American Journal of Cancer Research|July 10, 2023
Loss of MEG3 contributes to the enhanced migration and invasion in arsenic-induced carcinogenesis through NQO1/FSCN1 pathwayHuailu Tu, Zhuo Zhang, Jingxia Li, et al.
Toxicology and Applied Pharmacology|August 24, 2023
Isorhapontigenin (ISO) inhibits malignant cell transformation, migration, and invasion through MEG3/NEDD9 signaling in Cr(VI)-transformed cellsSophia Shi, Jingxia Li, Zhuo Zhang, et al.
Toxicology and Applied Pharmacology|June 26, 2025
Elevated SNHG1 promotes invasion and migration of Cd(II)-transformed cells through Sox2, Rac1, and SlugZhuo Zhang, Jingxia Li, Daneah Willis, et al.
International Journal of Molecular Sciences|May 14, 2025
Isorhapontigenin Inhibits Cell Growth, Angiogenesis, Migration, and Invasion of Non-Small-Cell Lung Cancer Cells Through NEDD9 SignalingZhuo Zhang, Jingxia Li, Daneah Willis, et al.
Heliyon|September 1, 2022
Loss of MEG3 and upregulation of miR-145 play an important role in the invasion and migration of Cr(VI)-transformed cellsZhuo Zhang, Jingxia Li, Bo Yan, et al.
Cancer Letters|July 31, 2021
Isorhapontigenin (ISO) inhibits EMT through FOXO3A/METTL14/VIMENTIN pathway in bladder cancer cellsNing Zhang, Xiaohui Hua, Huailu Tu, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Biomolecules|November 3, 2020
XIAP's Profile in Human CancerHuailu Tu, Max Costa
American Journal of Cancer Research|July 10, 2023
Loss of MEG3 contributes to the enhanced migration and invasion in arsenic-induced carcinogenesis through NQO1/FSCN1 pathwayHuailu Tu, Zhuo Zhang, Jingxia Li, et al.
Toxicology and Applied Pharmacology|August 24, 2023
Isorhapontigenin (ISO) inhibits malignant cell transformation, migration, and invasion through MEG3/NEDD9 signaling in Cr(VI)-transformed cellsSophia Shi, Jingxia Li, Zhuo Zhang, et al.
Toxicology and Applied Pharmacology|June 26, 2025
Elevated SNHG1 promotes invasion and migration of Cd(II)-transformed cells through Sox2, Rac1, and SlugZhuo Zhang, Jingxia Li, Daneah Willis, et al.
International Journal of Molecular Sciences|May 14, 2025
Isorhapontigenin Inhibits Cell Growth, Angiogenesis, Migration, and Invasion of Non-Small-Cell Lung Cancer Cells Through NEDD9 SignalingZhuo Zhang, Jingxia Li, Daneah Willis, et al.
Heliyon|September 1, 2022
Loss of MEG3 and upregulation of miR-145 play an important role in the invasion and migration of Cr(VI)-transformed cellsZhuo Zhang, Jingxia Li, Bo Yan, et al.
Cancer Letters|July 31, 2021
Isorhapontigenin (ISO) inhibits EMT through FOXO3A/METTL14/VIMENTIN pathway in bladder cancer cellsNing Zhang, Xiaohui Hua, Huailu Tu, et al.
Pageof 1